Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients

Parving, 2000, Diabetic nephropathy, 731 Parving, 1988, Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin-dependent diabetes, Br Med J, 296, 156, 10.1136/bmj.296.6616.156 Lewis, 1993, The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy, N Engl J Med, 329, 1456, 10.1056/NEJM199311113292004 Rossing, 1998, Promotion, prediction, and prevention of progression in diabetic nephropathy, Diabet Med, 15, 900, 10.1002/(SICI)1096-9136(1998110)15:11<900::AID-DIA709>3.0.CO;2-0 Parving, 1998, Renoprotection in diabetes: Genetic and non-genetic risk factors and treatment, Diabetologia, 41, 745, 10.1007/s001250050983 Zatz, 1986, Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension, J Clin Invest, 77, 1925, 10.1172/JCI112521 Crepaldi, 1998, Effects of lisinopril and nifedipine on the progression of overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure, Diabetes Care, 21, 104, 10.2337/diacare.21.1.104 Mathiesen, 1999, Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria, Br Med J, 319, 24, 10.1136/bmj.319.7201.24 Parving, 1989, Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy, Br Med J, 299, 533, 10.1136/bmj.299.6698.533 Parving, 1983, Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy, Lancet, 1, 1175, 10.1016/S0140-6736(83)92462-5 Bröchner-Mortensen, 1969, Renal inulin clearance versus total plasma clearance of 51Cr-EDTA, Scand J Clin Lab Invest, 23, 301, 10.3109/00365516909081695 Miles, 1970, Radioimmunoassay for urinary albumin using a single antibody, Scand J Clin Lab Invest, 26, 5, 10.3109/00365517009049206 Jensen, 1989, Micro-ELISA for the quantitation of human urinary and serum retinol-binding protein, Diabetes Res, 10, 93 Björck, 1992, Renal protective effect of enalapril in diabetic nephropathy, Br Med J, 304, 339, 10.1136/bmj.304.6823.339 Morelli, 1990, Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy, Diabetes, 39, 76, 10.2337/diacare.39.1.76 Imanishi, 1999, Glomerular hypertension as one cause of albuminuria in type II diabetic patients, Diabetologia, 42, 999, 10.1007/s001250051259 de Jong, 1999, Renoprotective therapy: Titration against urinary protein excretion, Lancet, 354, 352, 10.1016/S0140-6736(99)90122-8 Rossing, 1994, Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment, Diabetologia, 37, 511, 10.1007/s001250050140 Rossing, 1994, Reduction in albuminuria predicts diminished progression in diabetic nephropathy, Kidney Int, 45, S145 Apperloo, 1997, A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function, Kidney Int, 51, 793, 10.1038/ki.1997.111 Hansen, 1995, Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy, Kidney Int, 47, 1726, 10.1038/ki.1995.238 Greene, 1997, Interpretation of clinical studies of renal disease, 887